HRAS and breast cancer: Interestingly, nearly 70% of Wnt1-LateEx mammary tumors carried mutations in codon 61 of the Hras gene [47], which, in association with other PI3K/AKT pathway alterations, have also been recently identified as a main driver in the pathogenesis of AMEs in human [59].